Slobodan Tanaskovic

Prof. Dr. Slobodan Tanaskovic

Clinic for vascular and endovascular sugery, National Institute for heart and blood vessels "Dedinje", Belgrade, Beograd, Serbia
+1

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
DRDjordje Radak
Djordje Radak
Slobodan TanaskovicSlobodan Tanaskovic
Slobodan Tanaskovic
DSDragan Sagic
Dragan Sagic
ZAZelimir Antonic
Zelimir Antonic
SBSrdjan Babic
Srdjan Babic
ZRZoran Rancic
Zoran Rancic

9 May 2016 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
PDF file
DRDjordje Radak
Djordje Radak
Slobodan TanaskovicSlobodan Tanaskovic
Slobodan Tanaskovic
VKVladimir Kecmanovic
Vladimir Kecmanovic
SBSrdjan Babic
Srdjan Babic
PPPetar Popov
Petar Popov
PGPredrag Gajin
Predrag Gajin

1 July 2018 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
Slobodan TanaskovicSlobodan Tanaskovic
Slobodan Tanaskovic
DRDjordje Radak
Djordje Radak
NANikola Aleksic
Nikola Aleksic
BCBranko Calija
Branko Calija
VMVera Maravic-Stojkovic
Vera Maravic-Stojkovic
ZRZoran Rancic
Zoran Rancic

18 October 2015 in Angiology
Verified
Journal Article
Closed access
DRD. J. Radak
D. J. Radak
Slobodan TanaskovicSlobodan Tanaskovic
Slobodan Tanaskovic
HVHristina Vlajinac
Hristina Vlajinac
JMJ. M. Marinkovic
J. M. Marinkovic
MMM. Z. Maksimovic
M. Z. Maksimovic
In this study, we investigated whether the occurrence and intensity of leg pain are related to C class of the clinical, etiological, anatomical, and pathophysiological (CEAP) classification for chronic venous disease (CVeD). This cross-sectional study, conducted in Serbia, included 2841 patients: 2027 (71.3%) women and 814 (28.7%) men with CVeD diagnosed by general practitioners. For the first time, the Numeric Rating Scale of 0 to 5 units was used to assess the intensity of pain. For the analysis, univariate and multivariate logistic and linear regressions were applied. Pain in the legs was reported by 90.5% of the patients. The occurrence of pain significantly (P < .001) increased with increasing C class. Of the patients who reported pain in the legs, 42.0% had moderate pain, 23.7% had moderate to severe pain, 22.8% had light pain, 11.2% had severe pain, and 0.3% had very severe pain. Severity of pain differed significantly (P < .001) according to C class. Light and moderate pain gradually decreased and severe pain gradually increased from C0 to C6 class. These associations remained significant after adjustment for age, body mass index, and family history of CVeD.

1 October 2017 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
DRDjordje Radak
Djordje Radak
Slobodan TanaskovicSlobodan Tanaskovic
Slobodan Tanaskovic
DSDragan Sagic
Dragan Sagic
ZAZelimir Antonic
Zelimir Antonic
PGPredrag Gajin
Predrag Gajin
NINenad Ilijevski
Nenad Ilijevski

6 May 2013 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
DRDjordje Radak
Djordje Radak
JKJovo Kolar
Jovo Kolar
DSDragan Sagic
Dragan Sagic
NINenad Ilijevski
Nenad Ilijevski
Slobodan TanaskovicSlobodan Tanaskovic
Slobodan Tanaskovic
HVHristina Vlajinac
Hristina Vlajinac
Purpose: To assess the safety of endovascular treatment of chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis (MS). Materials and Methods: A total of 72 patients with CCSVI and MS (44 with relapsing remitting – RR, 4 with primary progressive, 20 with secondary progressive and 4 with benign MS) underwent percutaneous angioplasty. Outcome measures were colour Doppler ultrasonography parameters, gradient pressure at the vein abnormality level, postoperative complications, re-stenosis, disease severity scored by means of Expanded Disability Status Scale (EDSS) and patients’ assumption of disease status. Controls were done after one month on 72 patients, six months on 69 patients and one year on 61 patients, respectively (the average follow-up was 11 months). Results: There were no postoperative complications. Colour Doppler ultrasonography showed significant improvement in cross-sectional area parameters (P < 0.05) and significant decrease in confluence velocity values (P < 0.05). Postoperative gradient pressure decreased, in internal jugular vein (IJV) significantly (P < 0.05). Re-stenosis appeared in 5.3% of patients. EDSS score was significantly improved (P < 0.01) and about half of patients reported significant or mild improvement in disease status and none of them worsening of symptoms. Conclusion: Endovascular treatment of the IJV and azygous veins in patients with CCSVI and MS is a safe procedure with no post-procedural complications followed by significant improvement of IJV flow haemodynamic parameters and decrease in the EDSS score. Whether CCSVI percutaneous treatment might affect clinical improvement in patients suffering from MS is yet to be seen after completion of major multicentric clinical trials, still it seems like that this procedure is not negligible.